NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

Organization Name

LG Chem, Ltd.

Inventor(s)

Young Jin Ham of Daejeon (KR)

Joong Heui Cho of Daejeon (KR)

Hong Bin Yoon of Daejeon (KR)

Jung Joon Kim of Daejeon (KR)

Young Shin Kwak of Daejeon (KR)

Gyeong Hwan Kim of Daejeon (KR)

Ju Hyun Lee of Daejeon (KR)

NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR - A simplified explanation of the abstract

This abstract first appeared for US patent application 18569157 titled 'NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR

- Simplified Explanation:**

The patent application is for a novel compound that acts as a protein kinase inhibitor, specifically targeting the RON protein.

- Key Features and Innovation:**

- Novel compound designed as a protein kinase inhibitor - Specifically targets the RON protein - Potential for new treatment options in diseases related to RON protein activity

- Potential Applications:**

- Treatment of cancers and other diseases where RON protein plays a role - Research in understanding the role of RON protein in various biological processes

- Problems Solved:**

- Lack of specific inhibitors targeting the RON protein - Limited treatment options for diseases associated with RON protein overactivity

- Benefits:**

- Potential for more targeted and effective treatments - Advancement in understanding the role of RON protein in diseases

- Commercial Applications:**

- Potential for development of new pharmaceuticals targeting RON protein - Market implications in the field of cancer research and treatment

- Questions about Protein Kinase Inhibitors:**

1. What are the potential side effects of using protein kinase inhibitors in treatment?

  - Protein kinase inhibitors can have various side effects, including gastrointestinal issues, skin reactions, and cardiovascular problems.

2. How do protein kinase inhibitors differ from other types of cancer treatments?

  - Protein kinase inhibitors target specific proteins involved in cancer cell growth and survival, offering a more targeted approach compared to traditional chemotherapy.

Original Abstract Submitted

The present invention relates to a novel compound as a protein kinase inhibitor, particularly, a RON inhibitor.